Risankizumab (anti-IL-23)
Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn’s disease.
| Catalog Number | A2046 |
| CAS# | 1612838-76-2 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/risankizumab-anti-il-23.html |